Susquehanna International Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Susquehanna International Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-48,500	Closed	-$2.9M	–	11364
2019 Q4	$2.9M	Buy	48,500 +9,500	+24%	+$357K	﹤0.01%	3752
2019 Q3	$1.1M	Sell	39,000 -800	-2%	-$27.3K	﹤0.01%	5503
2019 Q2	$1.51M	Sell	39,800 -21,000	-35%	-$807K	﹤0.01%	4750
2019 Q1	$2.37M	Buy	60,800 +25,800	+74%	+$740K	﹤0.01%	3493
2018 Q4	$746K	Sell	35,000 -26,200	-43%	-$676K	﹤0.01%	5263
2018 Q3	$2.42M	Buy	61,200 +23,900	+64%	+$891K	﹤0.01%	3694
2018 Q2	$1.43M	Sell	37,300 -2,300	-6%	-$85.2K	﹤0.01%	4645
2018 Q1	$1.19M	Buy	+39,600	New	+$1.34M	﹤0.01%	4892

Susquehanna International Group's BOLD Position: Q1 2020 in Review

Susquehanna International Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 69,600 shares — an estimated $4.17M sold.

Susquehanna International Group first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $4.17M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Susquehanna International Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Susquehanna International Group sold 69,600 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.17M.
Susquehanna International Group first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
Susquehanna International Group's Audentes Therapeutics, Inc position peaked at $4.17M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.